论文部分内容阅读
目的:分析血液透析滤过联合血液灌流治疗尿毒症脑病的临床应用效果。方法:选取2013年6月到2014年8月我院尿毒症脑病患者60例,随机分为两组,其中对照组为30例,研究组为30例。给予对照组一般常规血液透析治疗,给予研究组血液透析滤过联合血液灌流治疗,对两组患者的治疗效果进行对比和分析。结果:给予两种不同的治疗方法后,对照组的治疗总有效率为50%,研究组的治疗总有效率为83%,组间数据对比差异明显,(P<0.05)具有统计学意义。结论:对尿毒症脑病患者采用血液透析滤过联合血液灌流治疗方法,效果显著,值得在临床上推广应用。
Objective: To analyze the clinical effect of hemodiafiltration combined with hemoperfusion on uremic encephalopathy. Methods: From June 2013 to August 2014, 60 patients with uremic encephalopathy in our hospital were randomly divided into two groups, of which 30 were in the control group and 30 in the study group. The control group was given routine hemodialysis, and the study group was given hemodiafiltration combined with hemoperfusion. The therapeutic effects of the two groups were compared and analyzed. Results: After two different treatments were given, the total effective rate of the control group was 50% and the total effective rate of the study group was 83%. There was significant difference between the two groups (P <0.05). Conclusion: Hemodialysis combined with hemoperfusion therapy for patients with uremic encephalopathy has a significant effect and is worth popularizing in clinic.